OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SALV54

Salvo Organic Industries PLC

Commodity ChemicalsVerified

Salvo Organic Industries PLC has a fully diluted share count of 65,022,794 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available in the valuation snapshot, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without disclosed revenue, EBITDA, or net income, it is not possible to evaluate the company’s performance against peers in the Commodity Chemicals industry. Segment and geographic exposure data are not disclosed in the available financials, making it impossible to assess revenue concentration or geographic diversification. The company does not provide segment-specific revenue breakdowns or geographic revenue distribution in its latest filings. Growth trajectory cannot be quantified due to the absence of historical revenue data or forward-looking guidance. The outlook for the current and next fiscal years remains undefined, as no numeric deltas or directional indicators are available in the input data. Risk factors include the inability to assess liquidity risk, as no balance-sheet inputs are available. The company also does not disclose any dilution sources, such as ATM programs, shelf registrations, or recent equity issuances. No dilution potential is identified in the custom valuations or risk assessment. Recent events, including filings or transcripts, are not available in the input data. No 10-K, 10-Q, or earnings call transcripts are provided to inform recent operational or strategic developments.

30-day price · SALV(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySalvo Organic Industries PLC
TickerSALV.DH
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Salvo Organic Industries PLC operates in the chemicals industry, producing commodity chemicals for industrial applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Salvo Organic Industries PLC has a fully diluted share count of 65,022,794 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available in the valuation snapshot, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without disclosed revenue, EBITDA, or net income, it is not possible to evaluate the company’s performance against peers in the Commodity Chemicals industry. Segment and geographic exposure data are not disclosed in the available financials, making it impossible to assess revenue concentration or geographic diversification. The company does not provide segment-specific revenue breakdowns or geographic revenue distribution in its latest filings. Growth trajectory cannot be quantified due to the absence of historical revenue data or forward-looking guidance. The outlook for the current and next fiscal years remains undefined, as no numeric deltas or directional indicators are available in the input data. Risk factors include the inability to assess liquidity risk, as no balance-sheet inputs are available. The company also does not disclose any dilution sources, such as ATM programs, shelf registrations, or recent equity issuances. No dilution potential is identified in the custom valuations or risk assessment. Recent events, including filings or transcripts, are not available in the input data. No 10-K, 10-Q, or earnings call transcripts are provided to inform recent operational or strategic developments.
Key takeaways
  • Salvo Organic Industries PLC operates in the Commodity Chemicals industry with no disclosed segment or geographic diversification.
  • The company has no dilution risk based on current share counts, but liquidity risk cannot be assessed.
  • Profitability and return metrics are not available, precluding a comparison to industry benchmarks.
  • Growth trajectory and risk factors remain undefined due to the absence of historical and forward-looking data.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2
FY-1
FY0
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1
FY0
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1
FY0
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSALVActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 02:00 UTC#5f817908
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 07:26 UTCJob: 67847282